Last quarter (Q3 2024), COSCIENS Biopharma's total revenue was $1.87M, an increase of 62266.67% from the same quarter last year. In Q3, COSCIENS Biopharma's net income was $-5.75M. See COSCIENS Biopharma’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Total Revenue	$ 4.33M	$ 4.50M	$ 5.64M	$ 5.26M	$ 3.65M	$ 532.00K
Cost of Revenue	$ 2.28M	$ ―	$ 157.00K	$ 90.00K	$ 1.96M	$ -410.00K
Gross Profit	$ 2.05M	$ 4.50M	$ 5.64M	$ -90.00K	$ 1.69M	$ -69.00K
Operating Expense	$ 24.26M	$ 22.23M	$ 20.67M	$ 13.84M	$ 7.40M	$ 9.67M
Operating Income	$ -22.21M	$ -17.73M	$ -15.03M	$ -13.93M	$ -5.71M	$ -9.73M
Net Non Operating Interest Income Expense	$ 636.00K	$ 1.13M	$ -3.00K	$ -21.00K	$ -1.39M	$ -593.00K
Other Income Expense	$ -2.63M	$ -273.00K	$ 8.57M	$ 3.23M	$ -8.00K	$ -4.52M
Pretax Income	$ -19.15M	$ -16.55M	$ -24.48M	$ -16.96M	$ -6.51M	$ -6.23M
Tax Provision	$ -586.00K	$ ―	$ ―	$ -109.00K	$ 395.00K	$ -188.00K
Earnings From Equity Interest Net Of Tax	$ ―	$ ―	$ ―	$ -3.23M	$ ―	$ ―
Net Income Common Stockholders	$ -18.56M	$ -16.55M	$ -24.48M	$ -16.85M	$ -6.91M	$ -7.03M
Basic EPS	$ -4.28	$ -3.41	$ -4.68	$ -1.82	$ -0.12	$ -0.35
Diluted EPS	$ -4.28	$ -3.41	$ -4.68	$ -1.82	$ -0.12	$ -0.35
Basic Average Shares	$ 11.40M	$ 4.86M	$ 4.86M	$ 4.60M	$ 41.08M	$ 17.49M
Diluted Average Shares	$ 11.40M	$ 4.86M	$ 4.86M	$ 4.60M	$ 41.08M	$ 20.08M
Dividend Per Share	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Total Operating Income As Reported	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Reported Normalized Basic E P S	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Reported Normalized Diluted E P S	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Rent Expense Supplemental	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Total Expenses	$ 26.54M	$ 22.23M	$ 20.67M	$ 13.93M	$ 9.36M	$ 9.26M
Net Income From Continuing And Discontinued Operation	$ -18.56M	$ -16.55M	$ -24.48M	$ -16.85M	$ -6.91M	$ -7.03M
Normalized Income	$ -18.72M	$ -12.70M	$ -9.64M	$ ―	$ ―	$ ―
Interest Expense	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
EBIT	$ -19.10M	$ -16.55M	$ -24.48M	$ -16.96M	$ -6.51M	$ -6.23M
EBITDA	$ -18.38M	$ -17.99M	$ -26.05M	$ -7.96M	$ -6.28M	$ -5.92M

Currency in USD

COSCIENS Biopharma Earnings and Revenue History

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing